"Dr. Snyder completed his undergraduate education in 1976 at the University of Syracuse. He received his medical degree from Universidad Autónoma De Guadalajara in 1980. As an expert urologist, Dr. Snyder has extensive knowledge of internal medicine, pediatrics, gynecology and other specialties.Dr. Snyder is certified by the American Board of Urology and is a Fellow of the American College of Surgeons. Prior to joining Urology Associates in 2018, Dr. Snyder headed Genitourinary Surgical Consultants, which he founded in 1992."

During the past decade, Genitourinary Surgical Consultants conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 9 clinical trials were completed, i.e. on average, 180% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genitourinary Surgical Consultants" #1 sponsor was "Ferring Pharmaceuticals" with 4 trials, followed by "Allergan" with 3 trials sponsored, "GTx" with 3 trials sponsored, "AEterna Zentaris" with 2 trials sponsored and "Solace Therapeutics, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genitourinary Surgical Consultants" #1 collaborator was "Regulatory and Clinical Research Institute (RCRI)" with 1 trials as a collaborator and "TARIS Biomedical, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Genitourinary Surgical Consultants" are "Stress Urinary Incontinence" (5 trials), "Nocturia" (3 trials), "Overactive Bladder" (3 trials), "Benign Prostatic Hypertrophy" (2 trials) and "Interstitial Cystitis" (1 trials). Many other conditions were trialed in "Genitourinary Surgical Consultants" in a lesser frequency.

Most popular intervention types in "Genitourinary Surgical Consultants" are "Drug" (14 trials), "Device" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "GTx-024" (2 trials), "onabotulinumtoxinA" (2 trials), "AttenueX IntraVesical System" (1 trials) and "Bulkamid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genitourinary Surgical Consultants" are 8 trials for "Female" genders, 5 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Genitourinary Surgical Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Genitourinary Surgical Consultants, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Genitourinary Surgical Consultants, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".